Drug Repurposing Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1062927
  • May 2021
  • Pharmaceuticals
  • 141 Pages
The global Drug Repurposing market research report provides complete study and detail analysis of the market. This study includes forecast analysis of the market which is based on global and regional level, whereas the research reports the provides forecast data from 2020-2028 and historic of 2018 and 2019. All the values are based on revenue USD Million. Moreover, the market research report describes various segments of the Drug Repurposing market based on its types, applications and end-use industry. The applications of the market are explained in different industry verticals with reference to major countries across the globe. Along with this, the research report also covers all the major players that are operating in the global Drug Repurposing market. These major players of the market are further studied and analyzed based on various parameters, such as annual market revenue, annual sales of the company, marketing strategy, historic growth and shipment volumes. Based on all the company’s insights, the market research analyst also suggests business strategy and marketing plans for improving the market position of existing participants of Drug Repurposing market.
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Astellas Pharma Inc., Biovista, Novartis AG, AbbVie Inc., Pfizer Inc., Allergan Plc., NuMedii, Abbott Healthcare, Hoffmann-La Roche, Johnson & Johnson
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Impact Analysis
The analysis of covid-19 is based on the impact of the current pandemic situation on market scenarios. This includes impact of covid-19 outbreak on overall revenue, market segments as well as regional market. The report also puts light on detailed impact analysis by taking into consideration all the government policies imposed during the pandemic situation, temporary shutdown of manufacturing units, current state of supply chain and distributors, and its future impacts on the growth of overall market. The market study will assist user to understand the global demand and impose strategic business plans to compete with the peers.

Apart from this, the market research report also covers drivers and restraints for the global Drug Repurposing market and their impact on the demand and supply during the forecast period. Along with this, the research report also provides Drug Repurposing market trends and opportunities that are based on regional and global level. Furthermore, the market research report also provides the major distributors and manufacturers that are operating in all the key region across the world. The researched data provided in the report is widely used by various industry players to strengthen their distribution channel and improve the geographical reach. In addition, the report also covers all the major players of the global Drug Repurposing market and its key offerings and solutions. The report also provides recent mergers and acquisitions of these key players.

The data which is provided in the market research report is analyzed and evaluated with the help of various marketing tools, such as SWOT analysis, Poster’s Five Force analysis, PESTEL analysis, value chain analysis, player positioning analysis and market share analysis. Therefore, this analysis tools helps the analyst to evaluate the Drug Repurposing market based on various parameters such as capital investments, impact of consumer’s preferences, economies of scale, manufacturing rights and patents, existing distribution channels, switching costs, government regulations and brand loyalty.

Major Key Players for Global Drug Repurposing Market:
The Drug Repurposing market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Astellas Pharma Inc., Biovista, Novartis AG, AbbVie Inc., Pfizer Inc., Allergan Plc., NuMedii, Abbott Healthcare, Hoffmann-La Roche, Johnson & Johnson

Drug Repurposing Market Segment Analysis:
By Disease Indication
Oncology
CNS Diseases
Neurodegenerative diseases
Others
End User
Hospitals
Ambulatory Surgical Centers
Others


Geographic Coverage for Drug Repurposing Market:
The market research report on global Drug Repurposing market offers complete analysis across various regions across the world. The Drug Repurposing market is distributed into various regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The global leading market share as per the region is evaluated after considering Drug Repurposing market revenue, sales, shares, recent developments, innovations and growth rates. This section of regional analysis provides widespread evaluation of the industry from various countries and regions.

North America Drug Repurposing Market Value and Forecast
  • US
  • Canada
Europe Drug Repurposing Market Value and Forecast
  • UK
  • Germany
  • France
  •  Rest of Europe
Asia Pacific Drug Repurposing Market Value and Forecast
  • China
  • Japan
  • India
  • Rest of Asia Pacific
Latin America Drug Repurposing Market Value and Forecast
  • Mexico
  • Brazil
  • Rest of Latin America
Middle East and Africa Drug Repurposing Market Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa


Key highlights of the Drug Repurposing market report:
  • The report provides key trends of the global Drug Repurposing market
  • The report also covers consumer preferences and current industry growth
  • Key products or solutions offered by the main players in the Drug Repurposing industry
  • The report covers all the recent developments of the Drug Repurposing market and helps to provide current industry updates
  • The report covers a detailed look over the global Drug Repurposing Industry and provides with significant actionable insights
  • The Drug Repurposing market estimation from 2020-2028 and historical data for 2018 and 2019
  • The market study also provides data on changing market dynamics, market intelligence, current and future market trends
  • The report also analyses the microeconomic and macroeconomic factors that are affecting the global Drug Repurposing market
  • In-depth analysis of the market’s competitive landscape and detailed information about the vendors
  • The report also offers key market drivers, restrains, trends and opportunities with present and future impact on the market
  • Detailed information about the major players or manufacturers of the global Drug Repurposing market
  • Comprehensive analysis of the Drug Repurposing market segments based on its types, applications and end-use industry
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Drug Repurposing market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Drug Repurposing market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

      2.  Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Drug Repurposing market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Drug Repurposing market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

      3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Drug Repurposing market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Astellas Pharma Inc.
  • Biovista
  • Novartis AG
  • AbbVie Inc.
  • Pfizer Inc.
  • Allergan Plc.
  • NuMedii
  • Abbott Healthcare
  • Hoffmann-La Roche
  • Johnson & Johnson
  • Oncology
  • CNS Diseases
  • Neurodegenerative diseases
  • Others
  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Drug Repurposing Market Snapshot
          2.1.1. Global Drug Repurposing Market By Disease Indication,2019
               2.1.1.1.Oncology
               2.1.1.2.CNS Diseases
               2.1.1.3.Neurodegenerative diseases
               2.1.1.4.Others
          2.1.2. Global Drug Repurposing Market By End User,2019
               2.1.2.1.Hospitals
               2.1.2.2.Ambulatory Surgical Centers
               2.1.2.3.Others
          2.1.3. Global Drug Repurposing Market By End-use,2019
          2.1.4. Global Drug Repurposing Market By Geography,2019

3. Global Drug Repurposing Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Drug Repurposing Market Size (US$), By Disease Indication, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Disease Indication, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Disease Indication, 2020
     4.2. Global Drug Repurposing Market Size (US$), By Disease Indication, 2018 – 2028

5. Global Drug Repurposing Market Size (US$), By End User, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By End User, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By End User, 2020
     5.2. Global Drug Repurposing Market Size (US$), By End User, 2018 – 2028

6. Global Drug Repurposing Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Drug Repurposing Market Size (US$), By End-use, 2018 – 2028

7. Global Drug Repurposing Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Drug Repurposing Market Analysis, 2018 – 2028 
          7.2.1. North America Drug Repurposing Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Drug Repurposing Market Size (US$), By Disease Indication, 2018 – 2028
          7.2.3. North America Drug Repurposing Market Size (US$), By End User, 2018 – 2028
          7.2.4. North America Drug Repurposing Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Drug Repurposing Market Analysis, 2018 – 2028 
          7.3.1.  Europe Drug Repurposing Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Drug Repurposing Market Size (US$), By Disease Indication, 2018 – 2028
          7.3.3. Europe Drug Repurposing Market Size (US$), By End User, 2018 – 2028
          7.3.4. Europe Drug Repurposing Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Drug Repurposing Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Drug Repurposing Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Drug Repurposing Market Size (US$), By Disease Indication, 2018 – 2028
          7.4.3. Asia Pacific Drug Repurposing Market Size (US$), By End User, 2018 – 2028
          7.4.4. Asia Pacific Drug Repurposing Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Drug Repurposing Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Drug Repurposing Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Drug Repurposing Market Size (US$), By Disease Indication, 2018 – 2028
          7.5.3. Latin America Drug Repurposing Market Size (US$), By End User, 2018 – 2028
          7.5.4. Latin America Drug Repurposing Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Drug Repurposing Market Analysis, 2018 – 2028 
          7.6.1.  MEA Drug Repurposing Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Drug Repurposing Market Size (US$), By Disease Indication, 2018 – 2028
          7.6.3. MEA Drug Repurposing Market Size (US$), By End User, 2018 – 2028
          7.6.4. MEA Drug Repurposing Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Drug Repurposing Providers
        8.4.1 Astellas Pharma Inc.
                8.4.1.1 Business Description
                8.4.1.2 Astellas Pharma Inc. Geographic Operations
                8.4.1.3 Astellas Pharma Inc. Financial Information
                8.4.1.4 Astellas Pharma Inc. Product Positions/Portfolio
                8.4.1.5 Astellas Pharma Inc. Key Developments
        8.4.2 Biovista
                8.4.2.1 Business Description
                8.4.2.2 Biovista Geographic Operations
                8.4.2.3 Biovista Financial Information
                8.4.2.4 Biovista Product Positions/Portfolio
                8.4.2.5 Biovista Key Developments
        8.4.3 Novartis AG
                8.4.3.1 Business Description
                8.4.3.2 Novartis AG Geographic Operations
                8.4.3.3 Novartis AG Financial Information
                8.4.3.4 Novartis AG Product Positions/Portfolio
                8.4.3.5 Novartis AG Key Developments
        8.4.4 AbbVie Inc.
                8.4.4.1 Business Description
                8.4.4.2 AbbVie Inc. Geographic Operations
                8.4.4.3 AbbVie Inc. Financial Information
                8.4.4.4 AbbVie Inc. Product Positions/Portfolio
                8.4.4.5 AbbVie Inc. Key Developments
        8.4.5 Pfizer Inc.
                8.4.5.1 Business Description
                8.4.5.2 Pfizer Inc. Geographic Operations
                8.4.5.3 Pfizer Inc. Financial Information
                8.4.5.4 Pfizer Inc. Product Positions/Portfolio
                8.4.5.5 Pfizer Inc. Key Developments
        8.4.6 Allergan Plc.
                8.4.6.1 Business Description
                8.4.6.2 Allergan Plc. Geographic Operations
                8.4.6.3 Allergan Plc. Financial Information
                8.4.6.4 Allergan Plc. Product Positions/Portfolio
                8.4.6.5 Allergan Plc. Key Developments
        8.4.7 NuMedii
                8.4.7.1 Business Description
                8.4.7.2 NuMedii Geographic Operations
                8.4.7.3 NuMedii Financial Information
                8.4.7.4 NuMedii Product Positions/Portfolio
                8.4.7.5 NuMedii Key Developments
        8.4.8 Abbott Healthcare
                8.4.8.1 Business Description
                8.4.8.2 Abbott Healthcare Geographic Operations
                8.4.8.3 Abbott Healthcare Financial Information
                8.4.8.4 Abbott Healthcare Product Positions/Portfolio
                8.4.8.5 Abbott Healthcare Key Developments
        8.4.9 Hoffmann-La Roche
                8.4.9.1 Business Description
                8.4.9.2 Hoffmann-La Roche Geographic Operations
                8.4.9.3 Hoffmann-La Roche Financial Information
                8.4.9.4 Hoffmann-La Roche Product Positions/Portfolio
                8.4.9.5 Hoffmann-La Roche Key Developments
        8.4.10 Johnson & Johnson
                8.4.10.1 Business Description
                8.4.10.2 Johnson & Johnson Geographic Operations
                8.4.10.3 Johnson & Johnson Financial Information
                8.4.10.4 Johnson & Johnson Product Positions/Portfolio
                8.4.10.5 Johnson & Johnson Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Drug Repurposing Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Drug Repurposing Market Revenue, By Disease Indication, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Drug Repurposing Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Drug Repurposing Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Drug Repurposing Market Revenue, By Disease Indication, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Drug Repurposing Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Drug Repurposing Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Drug Repurposing Market Revenue, By Disease Indication, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Drug Repurposing Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Drug Repurposing Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Drug Repurposing Market Revenue, By Disease Indication, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Drug Repurposing Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Drug Repurposing Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Drug Repurposing Market Revenue, By Disease Indication, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Drug Repurposing Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Drug Repurposing Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Drug Repurposing: Market Segmentation 
FIG. 2 Global Drug Repurposing Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Drug Repurposing Market, By Disease Indication, 2019 (US$ Mn) 
FIG. 5 Global Drug Repurposing Market, By End User, 2019 (US$ Mn) 
FIG. 6 Global Drug Repurposing Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Drug Repurposing Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Drug Repurposing Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Drug Repurposing Providers, 2019
FIG. 11 Global Drug Repurposing Market Revenue Contribution, By Disease Indication, 2019 & 2028 (Value %) 
FIG. 12 Global Drug Repurposing Market Revenue Contribution, By End User, 2019 & 2028 (Value %) 
FIG. 13 Global Drug Repurposing Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Drug Repurposing Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Drug Repurposing Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Drug Repurposing Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Drug Repurposing Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Drug Repurposing Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Drug Repurposing market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Drug Repurposing Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Drug Repurposing Market Value, By Segment1, 2018 – 2028
TABLE  North America Drug Repurposing Market Value, By Segment2, 2018 – 2028
TABLE  North America Drug Repurposing Market Value, By Country, 2018 – 2028
TABLE  Europe Drug Repurposing Market Value, By Segment1, 2018 – 2028
TABLE  Europe Drug Repurposing Market Value, By Segment2, 2018 – 2028
TABLE  Europe Drug Repurposing Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Drug Repurposing Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Drug Repurposing Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Drug Repurposing Market Value, By Country, 2018 – 2028
TABLE  Latin America Drug Repurposing Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Drug Repurposing Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Drug Repurposing Market Value, By Country, 2018 – 2028
TABLE  MEA Drug Repurposing Market Value, By Segment1, 2018 – 2028
TABLE  MEA Drug Repurposing Market Value, By Segment2, 2018 – 2028
TABLE  MEA Drug Repurposing Market Value, By Country, 2018 – 2028
TABLE  Astellas Pharma Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Biovista: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Novartis AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  AbbVie Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Pfizer Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Allergan Plc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  NuMedii: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Abbott Healthcare: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Hoffmann-La Roche: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Johnson & Johnson: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Drug Repurposing Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Drug Repurposing Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Drug Repurposing Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Drug Repurposing Market, By Geography, 2019 (US$ Mn)
FIG.  Global Drug Repurposing Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Drug Repurposing Providers, 2016
FIG.  Global Drug Repurposing Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global CNS Diseases Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Neurodegenerative diseases Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Drug Repurposing Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Ambulatory Surgical Centers Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Drug Repurposing Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Drug Repurposing Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Drug Repurposing Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Drug Repurposing Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Drug Repurposing Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Drug Repurposing Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Drug Repurposing Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Drug Repurposing Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Drug Repurposing Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Drug Repurposing Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Drug Repurposing Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Drug Repurposing Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Drug Repurposing Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Drug Repurposing Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Drug Repurposing Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Drug Repurposing Market Value, 2018 – 2028, (US$ Mn)